Signifier Medical Technologies
PrivateLast Round
Series E
Jun 28, 2023
Total Funding Raised
$82.34M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Signifier Medical Technologies operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Series E round in June 2023.
Signifier Medical Technologies is a medical technology company that develops and commercializes non-invasive solutions for patients with sleep-disordered breathing conditions and snoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Signifier Medical Technologies Comparables
Compare Signifier Medical Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sommetrics | 77% | |
| Somnics, Inc. | 76% | |
| ProSomnus, Inc. | 76% |
For institutional investors. Book with your work email.
Signifier Medical Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jun 28, 2023 | ||||
| Secondary | Mar 22, 2022 | ||||
| Series D | Jul 27, 2021 | ||||
| Series D | Jun 1, 2021 | ||||
| Series C | Sep 16, 2020 | ||||
Series B | Jun 17, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Signifier Medical Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Pritzker Organization | Series C, Series B |
| Innovate UK | Grant |
| Segulah Medical Acceleration | Series E, Secondary, Series D |
| SPEECA LIMITED | Series D |
| Umbra Capital Partners | Series C |
| Waha Capital | Secondary |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Grew 25% QoQ, from 12 to 15 employees.
- Mar 1, 2026
Monthly visitors increased 34% MoM.
For institutional investors. Book with your work email.
Signifier Medical Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Signifier Medical Technologies's valuation, stock price, and market status.
Is Signifier Medical Technologies a public or private company?
Signifier Medical Technologies is a private company.
What is the current stock price of Signifier Medical Technologies?
Signifier Medical Technologies is a private company, so its shares have no public market price. Caplight tracks Signifier Medical Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Signifier Medical Technologies worth (valuation)?
Valuation information for Signifier Medical Technologies is not publicly available.
Can I buy Signifier Medical Technologies stock?
Signifier Medical Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Signifier Medical Technologies's last funding round?
Signifier Medical Technologies's most recent funding round was Series E on June 28, 2023.
Who are the main investors in Signifier Medical Technologies?
Key investors in Signifier Medical Technologies include The Pritzker Organization, Segulah Medical Acceleration, Waha Capital.
Will Signifier Medical Technologies IPO soon?
No public IPO plans have been announced for Signifier Medical Technologies.
How can I track Signifier Medical Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Signifier Medical Technologies's shares on secondary markets.